Skip to content

Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease

Motivational Interviewing for Weight Loss in the Management of Non Alcoholic Fatty Liver Disease - A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06348628
Enrollment
231
Registered
2024-04-05
Start date
2022-05-31
Completion date
2025-06-24
Last updated
2025-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Alcoholic Fatty Liver Disease

Keywords

Motivational Interview, Randomized Controlled Trial

Brief summary

The goal of this study is to assess if motivational counselling works to reduce the weight in participants with Non Alcoholic Fatty Liver Disease (NAFLD).

Detailed description

Participants with NAFLD who meet inclusion and exclusion criteria and who give informed written consent, will be randomly assigned to the intervention and control group. Randomization will be done by using a random sequence generator with concealed allocation.

Interventions

BEHAVIORALMotivational Interview

4 Motivational interviews within first 6 months

BEHAVIORALPlacebo

Advices on standard of care treatment of NAFLD within first 6 months

Sponsors

Madunil Anuk Niriella
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18 years to 60 years * Body Mass Index (BMI) is 25 kg/m\^2 or more * Newly diagnosed with NAFLD based on clinical history, ultrasound scan and laboratory values

Exclusion criteria

* Any medical condition that will significantly alter the weight eg: hypothyroidism, hyperthyroidism, Cushing disease * Having moderate/severe depressive disorders or psychotic symptoms and or substance use disorders that would reduce their capacity to give consent and engage in Motivational interview * Who are on drugs which will affect weight or mood/affect (eg: corticosteroids) * Pregnancy or expecting to be conceive within the study period * Having any health conditions that would impede engagement in physical activities * Having any health conditions that would compromise the ability to follow the recommended dietary behaviors * Concurrent involvement in another weight loss programme

Design outcomes

Primary

MeasureTime frameDescription
Change in total fat percentage and visceral fat percentage after 1 year compared to baselineBaseline and 12 monthsBoth are measured by impedance method.
Change in Aspartate aminotransferase (AST) level and Alanine aminotransferase (ALT) level after 1 year compared to baselineBaseline and 12 monthsLower AST and ALT levels have a better outcome
Change in platelet count after 1 year compared to baselineBaseline and 12 monthsLower platelet count has a poor outcome
Change in waist circumference and hip circumference after 1 year compared to baselineBaseline and 12 monthsThe waist circumference is measured at the narrowest part of the waist. The hip circumference is measured at the widest part of the hips. Both are measured by using a measuring tape.
Change in weight after 1 year compared to baselineBaseline, 3 months, 6 months, 12 monthsWeight is measured using a digital scale

Secondary

MeasureTime frameDescription
Change in depression, anxiety and stress after 1 year compared to baselineBaseline, 12 monthsIt is assessed using the Depression, Anxiety and Stress Scale-21 (DASS-21). The minimum value for depression is 0 while maximum value is 28. A score more than 21 means severe depression. A minimum value for anxiety is 0 while maximum value is 20. A score more than 15 means severe anxiety. A minimum value for stress is 0 while maximum value is 34. A score more than 26 means severe stress.
Change in quality of life after 1 year compared to baselineBaseline, 12 monthsIt is assessed using the World Health Organization Quality of Life Brief (WHOQOL-BREF) version. The minimum value is 0 and the maximum value is 100. A lower score indicates poor quality of life while a higher score indicates a good quality of life.
Change in motivation for weight loss after 1 year compared to baselineBaseline, 12 monthsIt is assessed using the validated self-report University of Rhode Island Change Assessment (URICA) scale. The minimum value is -2 and the maximum value is +14. a higher score means a better outcome while a lower score means a poor outcome.

Countries

Sri Lanka

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026